Safeners Improve Maize Tolerance under Herbicide Toxicity Stress by Increasing the Activity of Enzymes in Vivo

2019 ◽  
Vol 67 (42) ◽  
pp. 11568-11576 ◽  
Author(s):  
Fei Ye ◽  
Yue Zhai ◽  
Ke-Liang Guo ◽  
Yong-Xuan Liu ◽  
Na Li ◽  
...  
Keyword(s):  
Activity Of Enzymes ◽  
Herbicide Toxicity

scholarly journals Antiviral proteinase inhibitors of plant and animal origin

2020 ◽  
Vol 2 (2) ◽  
pp. 43-48
Author(s):  
Valentina Divocha ◽  
◽  
Irina Komarevzeva ◽  
Keyword(s):  
Influenza Virus ◽  
Trypsin Inhibitor ◽  
Proteinase Inhibitors ◽  
Animal Origin ◽  
Ether Anesthesia ◽  
The Past ◽  
Activity Of Enzymes ◽  
Academy Of Sciences ◽  
Observation Period

Introduction: Over the past 10 years, much attention has been paid to the development of new antiviral drugs based on the suppression of the proteolytic activity of enzymes by trypsin inhibitors of plant and animal origin. Material and methods: We used a trypsin inhibitor from barley, trielin- (isolated by employees of the Agro-Industrial Institute of Selection and Genetics of the Ukrainian Academy of Sciences from the salivary glands of a dog); ovomukoid (isolated from duck eggs by employees of N, I, Bach Research Institute of Biology, Russian Academy of Sciences); Influenza virus APR 8/34 (fourth passage), adapted to the lungs of mice at a dose of 20 LD /0.1 ml, titre HA( hemagglutenin) 1:32) ,white BALB/c mice weighing 12-14 g. Infection with influenza virus and treatment with inhibitors was carried out intranasally under light ether anesthesia. Doses studied were: 0.5mg/ml; 2.5 mg/ml; 5.0 mg/ml; The treatment regimen of 10 mg/ml differed only in the initial stages (1 hour before infection, during infection and 1 hour after infection, and then 6 hours after infection, 24 hours after infection, 48 hours after infection, 72 hours after infection and 96 hours after infection). Results and discussion: We found that an in vivo inhibitor from barley at a dose of 10 g/l delayed the development of influenza for 8 days. The ovomukoid possessed only prophylactic properties at a dose of 100 gamma / ml. With an increase in dose, it was toxic to animals. Trielin at a dose of 10 g/l had a pronounced therapeutic effect in influenza and was not toxic. The presence of hemagglutinin influenza virus in the lungs of treated mice was observed only on the 10th day after infection; 40% of the animals remained alive for 14 days (observation period).

scholarly journals Influence of fullerenol C60(OH)24 on enzime status in serum of rats after single dose administration of doxorubicine

2008 ◽  
Vol 62 (3) ◽  
pp. 191-196 ◽  
Author(s):  
Biljana Govedarica ◽  
Vukosava Djordjevic-Milic ◽  
Natasa Radic ◽  
Branislava Srdjenovic ◽  
Aleksandar Djordjevic
Keyword(s):  
Enzyme Activity ◽  
Single Dose ◽  
Free Radicals ◽  
Side Effects ◽  
Topoisomerase Ii ◽  
Control Group ◽  
Limiting Factor ◽  
Dose Administration ◽  
Activity Of Enzymes

The antracycline antibiotics have one of the widest areas of use in oncology. The most investigated mechanisms of their antineoplastic activity include: interactions of these antibiotics with DNA, inhibition of topoisomerase II and production of free radicals. However, the side effects of doxorubicin, especially cardiotoxicity, are the limiting factor of its use in cancer therapy. The aim of this research was to investigate the influence of fullerenol ?60(?H)24 as a cytoprotector in single doze administration of doxorubicin on the activity of enzymes in serum (CK, AST, ALT, LDH and a-HBDH) in rats in in vivo system. Activity of enzymes (CK, LDH, HBDH, AST, and ALT) in serume was measured with standard commercial methods. The results of analysis of the samples treated with the combination of fullerenol and doxorubicin show no difference in enzyme activity in comparison with the control group. The results indicate the possibility of using fullerenol as a protector in the therapy with doxorubicin in malign neoplasm.

scholarly journals Immunological detection of fructated proteins in vitro and in vivo

1998 ◽  
Vol 336 (1) ◽  
pp. 101-107 ◽  
Author(s):  
Nobuko MIYAZAWA ◽  
Yoshimi KAWASAKI ◽  
Junichi FUJII ◽  
Myint THEINGI ◽  
Ayumu HOSHI ◽  
...  
Keyword(s):  
Reducing Sugars ◽  
Early Stage ◽  
Polyol Pathway ◽  
Diabetic Rat ◽  
Dependent Manner ◽  
Glycation End Products ◽  
Lysine Residues ◽  
Activity Of Enzymes

An antibody has been raised against fructated lysine in proteins by immunizing fructated lysine-conjugated ovalbumin in rabbits. The affinity-purified antibody specifically recognized proteins incubated with fructose but not with other reducing sugars such as glucose, galactose or ribose, as judged by immunoblotting and ELISA techniques. Competitive binding to this antibody was observed specifically by fructated lysine but not by glucated lysine, glucose, fructose or lysine. The antibody binds specifically to fructated lysine residues in the protein but not to borohydride-reduced material or advanced glycation end products, indicating that the antibody recognizes only the reducing, carbonyl-containing forms produced in the early stage of the fructation reaction. When BSA was incubated with various concentrations of fructose, the reactivity of the antibody increased in a dose- and time-dependent manner. When soluble proteins prepared from either normal or streptozotocin-induced diabetic rat eyes were analysed by ELISA with this antibody, an increase in the reactive components was observed as a function of aging as well as under diabetic conditions. Western blotting analysis showed that lens crystallin reacted highly with this antibody. Because fructose is biosynthesized largely through the polyol pathway, which is enhanced under diabetic conditions, and lens is known to have a high activity of enzymes in this pathway, this antibody is capable of recognizing fructated proteins in vivo. Thus it is a potentially useful tool for investigating two major issues that seem to be involved in diabetic complications, namely the glycation reaction and the polyol pathway.

scholarly journals Identification of bioactive compounds from Fraxinus angustifolia extracts with anti-NADH oxidase activity of bovine milk xanthine oxidoreductase

2019 ◽  
pp. 133-147 ◽  
Author(s):  
Nadjia AHMANE ◽  
Dina ATMANI-KILANI ◽  
Nassima CHAHER ◽  
Karima AYOUNI ◽  
Meriem RAHMANI-BERBOUCHA ◽  
...  
Keyword(s):  
Oxidase Activity ◽  
Nadh Oxidase ◽  
Bovine Milk ◽  
Ros Generation ◽  
Xanthine Oxidoreductase ◽  
Fraxinus Angustifolia ◽  
Activity Of Enzymes ◽  
Nadh Oxidase Activity

Fraxinus angustifolia leaves and bark are used in traditional medicine against various inflammatory-related pathologies incumbent to reactive oxygen species (ROS) generation by the NADH oxidase activity of enzymes such as xanthine oxidoreductase (XOR). This study was designed to investigate the in vitro and in vivo inhibitory activities of this enzyme by Fraxinus angustifolia extracts. The leaf organic phase of ethyl acetate (LFA) and its bark aqueous counterpart (BFA) showed the strongest anti-NADH oxidase activity in vitro (IC50 = 38.51 and 42.04 μg mL-1, respectively). They consequently suppressed superoxide generation both enzymatically (53% and 19%, respectively) and nonenzymatically (34% and 19%, respectively). These results were corroborated in vivo, with high anti- NADH oxidase potential of the leaves and bark extracts (75.32% and 51.32%, respectively) concomitant with moderate hypouricemic activities (36.84% and 38.59%, respectively). Bio-guided fractionation led to the identification, by LC-DAD-MS/MS, of esculin and calcelarioside in bark and kaempferol glucoside in leaves as the main compounds responsible for the anti-NADH oxidase activity of XOR. These results plead in favor of the use of F. angustifolia as a source of potentially interesting therapeutic substances.

Enzyme-based nanocomplexes and their construction for detoxification of organophosphorus compounds

2020 ◽  
pp. 361-379
Author(s):  
Elena Efremenko ◽  
Il'ya Lyagin ◽  
Aslanli Aslanli
Keyword(s):  
Immune Response ◽  
Human Body ◽  
Organophosphorus Compounds ◽  
The Body ◽  
Chemical Methods ◽  
Advantages And Disadvantages ◽  
Main Challenge ◽  
Activity Of Enzymes ◽  
Biological Methods

Organophosphorus compounds (OPC) pose a serious threat, as they can have a neurotoxic effect on the human body, even death. In this regard, the main challenge of our times is the search for effective ways of degradation of OPC. In this case, preference is given to biological methods of OPC detoxification, which do not require the use of harsh chemical methods of degradation and are suitable for in vivo use. One of such methods is the use of biocatalysts — enzymes capable of hydrolyzing OPC. To stabilize the activity of enzymes, as well as leveling a possible immune response from the body when used in vivo, various modification methods are used, such as nanocapsulation, the formation of enzymepolyelectrolyte complexes, immobilization of the enzyme on various functionalized carriers, etc. The chapter contains the information on examples of such biocatalysts, discussion of their advantages and disadvantages.

The Increased Rate of Activation of Factor XII in Late Pregnancy Can Contribute to the Increased Reactivity of Factor VII

1990 ◽  
Vol 63 (03) ◽  
pp. 349-355 ◽  
Author(s):  
K A Mitropoulos ◽  
J C Martin ◽  
A I Burgess ◽  
M P Esnouf ◽  
Y Stirling ◽  
...  
Keyword(s):  
Contact Surface ◽  
Late Pregnancy ◽  
Factor Vii ◽  
Factor Xii ◽  
Coagulant Activity ◽  
Activity Of Enzymes ◽  
And Control ◽  
Rate Of Activation

SummaryThe amidolytic activity of enzymes derived from factor XII (XIIa) was 3-fold higher in plasmas collected during pregnancy than from control subjects. Factor VII coagulant activity (VIIc) and XIIa increased in both kinds of plasmas on incubation on ice for 24 h (cold activation). These increases could be attributed to the decreased potency of C1 inhibitor (C1INH). However, variations in the concentration of C1INH and of factor XII could not explain the differences in VIIc and in XIIa between late pregnancy and control plasmas following cold activation under the same conditions. It is concluded that in vitro the increased amount of contact surface in the late pregnancy plasma promotes a higher rate of generation of XIIa and consequently a higher rate of activation of factor VII. The increased amount of contact surface could also be responsible for the increased concentration of XIIa in non-treated plasma from late pregnancy and could contribute in vivo to the higher reactivity of factor VII in this condition.

scholarly journals Dioxin exposure and porcine reproductive hormonal activity

2002 ◽  
Vol 18 (2) ◽  
pp. 453-462 ◽  
Author(s):  
Ewa L. Gregoraszczuk
Keyword(s):  
Corpora Lutea ◽  
Dependent Manner ◽  
Luteal Cells ◽  
Aryl Hydrocarbon ◽  
Preovulatory Follicles ◽  
Activity Of Enzymes ◽  
Primary Monolayer ◽  
Dioxin Exposure

To characterize the action of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) during both the follicular and luteal phases of the ovarian cycle, the direct effect of TCDD was investigated in vitro using a system of primary monolayer cell culture. Granulosa and theca cells were collected from the preovulatory follicles and cultured as a co-culture, thus resembling follicles in vivo. Luteal cells were isolated from the corpora lutea collected during the midluteal phase. In both cases cells were isolated from the ovaries of animals exhibiting natural estrus cycle. Results of these experiments suggest that TCDD decreases estradiol secretion by follicular cells and progesterone secretion by luteal cells in a dose-dependent manner. It was also shown that TCDD disrupts steroidogenesis through its influence on the activity of enzymes involved in the steroid biosynthesis cascade. In luteal cells, its action is mediated via the aryl hydrocarbon receptor (AhR) and is probably independent of estrogen receptor (ER) stimulation. Endocrine disruptors that interfere with estradiol production in the follicles can act as ovulatory disruptors, and while interfering with progesterone production by luteal cells they can act as abortifacients.

scholarly journals Enzyme Therapy: Current Challenges and Future Perspectives

2021 ◽  
Vol 22 (17) ◽  
pp. 9181
Author(s):  
Miguel de la Fuente ◽  
Laura Lombardero ◽  
Alfonso Gómez-González ◽  
Cristina Solari ◽  
Iñigo Angulo-Barturen ◽  
...  
Keyword(s):  
Immune Response ◽  
Field Research ◽  
High Throughput Analysis ◽  
Angiotensin Converting Enzyme 2 ◽  
Wide Range ◽  
Activity Of Enzymes ◽  
Target Molecules ◽  
Therapeutic Tools ◽  
Therapeutic Alternatives

In recent years, enzymes have risen as promising therapeutic tools for different pathologies, from metabolic deficiencies, such as fibrosis conditions, ocular pathologies or joint problems, to cancer or cardiovascular diseases. Treatments based on the catalytic activity of enzymes are able to convert a wide range of target molecules to restore the correct physiological metabolism. These treatments present several advantages compared to established therapeutic approaches thanks to their affinity and specificity properties. However, enzymes present some challenges, such as short in vivo half-life, lack of targeted action and, in particular, patient immune system reaction against the enzyme. For this reason, it is important to monitor serum immune response during treatment. This can be achieved by conventional techniques (ELISA) but also by new promising tools such as microarrays. These assays have gained popularity due to their high-throughput analysis capacity, their simplicity, and their potential to monitor the immune response of patients during enzyme therapies. In this growing field, research is still ongoing to solve current health problems such as COVID-19. Currently, promising therapeutic alternatives using the angiotensin-converting enzyme 2 (ACE2) are being studied to treat COVID-19.

In vivo Impact of Monocrotophos on Biochemical Parameters of a Freshwater Fish during Subacute Toxicity and Following Cessation of Exposure to the Insecticide

2011 ◽  
Vol 66 (9-10) ◽  
pp. 507-514 ◽  
Author(s):  
Madhusudan Reddy Narra ◽  
Ghousia Begum ◽  
Kodimyala Rajender ◽  
J. Venkateswara Rao
Keyword(s):  
Freshwater Fish ◽  
Recovery Period ◽  
Free Water ◽  
Protein Amino Acid ◽  
Subacute Toxicity ◽  
Muscle Tissues ◽  
Activity Of Enzymes ◽  
Recovery Response ◽  
Kidney Liver

In vivo toxicity of monocrotophos on key metabolites and enzymes of the protein metabolism was investigated in important tissues of the freshwater fish Clarias batrachus. Fish were exposed to 1/10 and 1/20 of LC50 concentration for 28 days. After 28 days of exposure, some fish were transferred to monocrotophos-free water and kept in the same for 21 days (recovery period) in order to study the recovery response. Total protein, amino acid, and ammonia contents were decreased in gill, kidney, liver, and muscle tissues, and recovery was slight at the end of 21 days of transfer of fish into freshwater. Urea and glutamine levels were elevated, except in kidneys, and recovered at the end of the recovery period. The activities of protease, transaminase, and phosphatase enzymes were elevated in all tissues during 28 days of exposure and at both concentrations. Recovery of the activity of enzymes was more significant at the lower concentration as compared to the higher concentration.

scholarly journals In vitro turnover numbers do not reflect in vivo activities of yeast enzymes

2021 ◽  
Vol 118 (32) ◽  
pp. e2108391118
Author(s):  
Yu Chen ◽  
Jens Nielsen
Keyword(s):  
Escherichia Coli ◽  
Saccharomyces Cerevisiae ◽  
Large Scale ◽  
Metabolic Model ◽  
Proteomics Data ◽  
Weak Correlation ◽  
E Coli ◽  
Activity Of Enzymes

Turnover numbers (kcat values) quantitatively represent the activity of enzymes, which are mostly measured in vitro. While a few studies have reported in vivo catalytic rates (kapp values) in bacteria, a large-scale estimation of kapp in eukaryotes is lacking. Here, we estimated kapp of the yeast Saccharomyces cerevisiae under diverse conditions. By comparing the maximum kapp across conditions with in vitro kcat we found a weak correlation in log scale of R2 = 0.28, which is lower than for Escherichia coli (R2 = 0.62). The weak correlation is caused by the fact that many in vitro kcat values were measured for enzymes obtained through heterologous expression. Removal of these enzymes improved the correlation to R2 = 0.41 but still not as good as for E. coli, suggesting considerable deviations between in vitro and in vivo enzyme activities in yeast. By parameterizing an enzyme-constrained metabolic model with our kapp dataset we observed better performance than the default model with in vitro kcat in predicting proteomics data, demonstrating the strength of using the dataset generated here.

Sign in / Sign up

Export Citation Format

Share Document